James Ward currently serves as Executive Director and Development Program Lead for Oncology and Rare Disease Therapeutics at Moderna since March 2023. Prior roles include Senior Medical Director at Seagen focused on clinical development in oncology (January 2021 - February 2023) and Medical Director at AbbVie, also in oncology clinical development (December 2016 - January 2021). James has academic experience as a Clinical Assistant Professor at the University of Chicago's Pritzker School of Medicine and has held various medical oncology positions at NorthShore University HealthSystem and University of California, Irvine. Educational qualifications include a Doctor of Medicine from Loyola University Chicago Stritch School of Medicine and a Bachelor of Science in Biology from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices